Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Endocrinology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters

Diabetes Mellitus, Type 1 Clinical Trials

A listing of Diabetes Mellitus, Type 1 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (128) clinical trials

One-day visit study to evaluate a new glucose meter Patient Inclusion Criteria: 12 years or older Must be able to perform self monitoring glucose testing without assistance Must be able to speak, read and write English

Phase N/A

If you are a man or woman over the age of 18, you may be eligible to participate in a clinical research study evaluating the safety and effectiveness of an investigational form of insulin in reducing blood sugar levels in individuals with Type 1 Diabetes. There is no cost to ...

Phase N/A

A 26-Week Study of the development of Type 1 Diabetes screening blood test to identify increased risk of Type 1 Diabetes Patient Inclusion Criteria: Patient must be between 7 and 45 years of age Patients ages 45 or younger with a parent, sibling, or child with DM1 Patients ages 20 ...

Phase

A one visit glucose meter study to evaluate user performance of the glucose monitoring system Fingerstick and AST testing.

Phase N/A

A study to evaluate the two new sensors performance in pediatric patients with insulin requiring diabetes

Phase N/A

The INSTRIDE Studies are looking to see how well an investigational insulin works to control blood sugar levels. The investigational insulin has been designed to be as similar as possible to insulin glargine (Lantus®), which has helped many people with diabetes worldwide. The investigational insulin could be a more affordable ...

Phase N/A

The study is a 2-arm, multicenter, 1:1 randomized, placebo controlled clinical trial. All subjects will receive close monitoring for development of AGT or T1DM. Subjects will receive Abatacept or placebo and close monitoring for development of AGT or T1DM. To assess the safety, efficacy, and mode of action of Abatacept ...

Phase

The study will determine whether the anti-CD3 monoclonal antibody, teplizumab, can help to prevent or delay the onset of type 1 diabetes (T1D) in relatives determined to be at very high risk for developing the disease. Teplizumab has been studied in new onset type 1 diabetes for testing of efficacy ...

Phase

This is a three-arm, 1:1:1 randomized, placebo controlled, double- blinded trial in which at least 28 subjects will receive active Anti-Thymocyte Globulin and Granulocyte colony-stimulating factor (ATG-GCSF), at least 28 subjects will receive ATG alone and at least 28 subjects will receive placebo alone within 100 days from diagnosis of ...

Phase

Type 1 diabetes (T1D) is an autoimmune disease. This means that the immune system (the part of the body which helps fight infections) mistakenly attacks and destroys the cells that produce insulin (islet cells found in the pancreas). As these cells are destroyed, the body's ability to produce insulin decreases. ...

Phase